Katalog der Deutschen Nationalbibliothek

Neuigkeiten

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

 
Neuigkeiten Die Lesesäle für Geisteswissenschaften, Naturwissenschaften, der Alte Lesesaal Technik und der Anne-Frank-Shoah-Lesesaal in Leipzig schließen am 04.02.2026 wegen einer Veranstaltung bereits um 15 Uhr. Die weiteren Lesesäle sowie die Servicetheke sind zu den regulären Zeiten geöffnet. //
The humanities reading room, the natural science reading room, the old technology reading room and the reading room of the Anne-Frank-Shoah-Library will close at 15:00 on 4 February 2026 due to an event. The other reading rooms and the service desk will be open during regular hours.
 
 
 


Ergebnis der Suche nach: Placebo
im Bestand: Gesamter Bestand

8961 - 8970 von 9948
<< < > >>


Artikel 8961 Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Learnings from a Double-Blind, Randomized, Placebo-Controlled, Sequential Group First-in-Human Study of the TRPV1 Antagonist, JNJ-38893777, in Healthy Men
Enthalten in Clinical drug investigation Bd. 35, 17.4.2015, Nr. 6, date:6.2015: 353-363
Online Ressource
Artikel 8962 Safety, Tolerability and Pharmacokinetic-Pharmacodynamic Relationship of NX210c Peptide in Healthy Elderly Volunteers: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study
Enthalten in Neurology and Therapy Bd. 14, 21.12.2024, Nr. 1, date:2.2025: 357-377
Online Ressource
Artikel 8963 Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects
Enthalten in Clinical drug investigation Bd. 31, 24.8.2012, Nr. 5, date:5.2011: 325-335
Online Ressource
Artikel 8964 Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
Enthalten in Advances in therapy Bd. 40, 15.2.2023, Nr. 4, date:4.2023: 1628-1643
Online Ressource
Artikel 8965 Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects
Enthalten in Clinical drug investigation Bd. 30, 24.8.2012, Nr. 12, date:12.2010: 867-874
Online Ressource
Artikel 8966 Safety, Tolerability, and Pharmacokinetic Study of 101BHG-D01 Nasal Spray, a Novel Long-Acting and Selective Cholinergic M Receptor Antagonist, in Healthy Chinese Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation, First-In-Human Study
Enthalten in European journal of drug metabolism and pharmacokinetics Bd. 47, 16.4.2022, Nr. 4, date:7.2022: 509-521
Online Ressource
Artikel 8967 Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
Enthalten in Advances in therapy Bd. 40, 26.5.2023, Nr. 7, date:7.2023: 3186-3198
Online Ressource
Artikel 8968 Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers
Enthalten in Infectious diseases and therapy Bd. 13, 4.8.2024, Nr. 9, date:9.2024: 2053-2070
Online Ressource
Artikel 8969 Safety, Tolerability, and Pharmacokinetics of NRL-1049, a Rho-Associated Kinase Inhibitor, in Healthy Volunteers: A Phase 1, First-in-Human, Single-Ascending Dose, Randomized, Placebo-Controlled Trial
Enthalten in CNS drugs Bd. 39, 8.7.2025, Nr. 9, date:9.2025: 865-877
Online Ressource
Artikel 8970 Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial
Enthalten in BMC pharmacology & toxicology Bd. 21, 6.1.2020, Nr. 1, date:12.2020: 1-10
Online Ressource


8961 - 8970 von 9948
<< < > >>


E-Mail-IconAdministration